CSPG4 and glioblastoma: Among nine CS-modified proteins (CSPGs) reported in human, CSPG4 was significantly upregulated in GBMs compared with normal tissues (Fig. 5A) and was found to be associated with poor prognosis in GBM patients (Fig. 5B).